Eton Pharmaceuticals, Inc. ETON License — Cost of Goods Sold

Similar metrics at other companies

PVHLicensing Segment — Cost of goods sold

$0—

SSNCLicense And Maintenance — Cost of Goods Sold

$104.8M+5.3%

AVPTTermed License And Support — Cost of Goods Sold

$281K-50.2%

MANHLicense And Maintenance — Cost of Goods Sold

$564K+170%

TVTXLicense and collaboration revenue — Cost of goods sold

$0-100%

BBLicensing — Cost of Sales

$1.5M-6.3%

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s license — cost of goods sold?

Eton Pharmaceuticals, Inc. (ETON) reported license — cost of goods sold of $0 in Q1 2026.

How has Eton Pharmaceuticals, Inc.'s license — cost of goods sold changed year-over-year?

Eton Pharmaceuticals, Inc.'s license — cost of goods sold decreased by 100.0% year-over-year, from $825K to $0.

What is the long-term trend for Eton Pharmaceuticals, Inc.'s license — cost of goods sold?

Over 4 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s license — cost of goods sold has grown at a -13.9% compound annual growth rate (CAGR), from $1.5M to $825K.

What does license — cost of goods sold mean?

Includes the direct costs incurred to support the delivery of licensed products or services, such as royalties, manufacturing overhead, or third-party distribution fees. Tracking this metric allows for the assessment of the direct profitability and margin profile of the licensing business segment. It is essential for evaluating the efficiency of the company's cost structure in relation to its licensing revenue.